These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16076691)

  • 21. Angiogenesis inhibition in the treatment of colorectal cancer Part 3 of a 3-part series: targeting VEGF--current and future research directions.
    Goldberg RM; Hurwitz HI; Fuchs CS
    Clin Adv Hematol Oncol; 2005 Dec; 3(12):1-10; quiz 11. PubMed ID: 16555433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognizing and managing toxicities of molecular targeted therapies for colorectal cancer.
    Grothey A
    Oncology (Williston Park); 2006 Dec; 20(14 Suppl 10):21-8. PubMed ID: 17354514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical use of anti-vascular endothelial growth factor monoclonal antibodies in metastatic colorectal cancer.
    Chase JL
    Pharmacotherapy; 2008 Nov; 28(11 Pt 2):23S-30S. PubMed ID: 18980549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiangiogenesis agents in colorectal cancer.
    Hubbard J; Grothey A
    Curr Opin Oncol; 2010 Jul; 22(4):374-80. PubMed ID: 20375894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Colon cancer: what is new in 2004?].
    André T; Louvet C; de Gramont A
    Bull Cancer; 2004 Jan; 91(1):75-80. PubMed ID: 14975808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future directions in vascular endothelial growth factor-targeted therapy for metastatic colorectal cancer.
    Grothey A
    Semin Oncol; 2006 Oct; 33(5 Suppl 10):S41-9. PubMed ID: 17145524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancer.
    Van Cutsem E
    Oncologist; 2006 Oct; 11(9):1010-7. PubMed ID: 17030643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal perforation due to bevacizumab in colorectal cancer.
    Saif MW; Elfiky A; Salem RR
    Ann Surg Oncol; 2007 Jun; 14(6):1860-9. PubMed ID: 17356952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A perspective: role of targeted therapy in colon cancer].
    Chung HH; Jang BI
    Korean J Gastroenterol; 2013 Mar; 61(3):128-35. PubMed ID: 23575231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted therapy in rectal cancer.
    Willett CG; Duda DG; Czito BG; Bendell JC; Clark JW; Jain RK
    Oncology (Williston Park); 2007 Aug; 21(9):1055-65; discussion 1065, 1070, 1075 passim. PubMed ID: 17910311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bevacizumab and cetuximab for colorectal cancer.
    Drug Ther Bull; 2006 May; 44(5):37-40. PubMed ID: 16706233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies in the treatment of advanced colorectal cancer.
    Capdevila J; Saura C; Macarulla T; Casado E; Ramos FJ; Tabernero J
    Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S24-34. PubMed ID: 17981431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CALGB/SWOG C80405: A phase III trial of FOLFIRI or FOLFOX with bevacizumab or cetuximab or both for untreated metastatic adenocarcinoma of the colon or rectum.
    Clin Adv Hematol Oncol; 2006 Jun; 4(6):452-3. PubMed ID: 16981668
    [No Abstract]   [Full Text] [Related]  

  • 34. Targeted therapy in colorectal cancer: do we know enough?
    Pantaleo MA; Palassini E; Labianca R; Biasco G
    Dig Liver Dis; 2006 Feb; 38(2):71-7. PubMed ID: 16289975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted strategies in the treatment of metastatic colon cancer.
    Reidy D; Saltz L
    J Natl Compr Canc Netw; 2007 Oct; 5(9):983-90. PubMed ID: 17977504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-based therapies for colorectal cancer.
    Chung KY; Saltz LB
    Oncologist; 2005 Oct; 10(9):701-9. PubMed ID: 16249350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological therapy and other novel therapies in early-stage disease: are they appropriate?
    Grothey A
    Clin Cancer Res; 2007 Nov; 13(22 Pt 2):6909s-12s. PubMed ID: 18006799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of approaches to adjuvant therapy for colorectal cancer in the United States.
    Hobday TJ
    Clin Colorectal Cancer; 2005 Apr; 5 Suppl 1():S11-8. PubMed ID: 15871761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted therapy in colorectal cancer.
    Wadler S
    Clin Colorectal Cancer; 2007 Jan; 6(5):357-61. PubMed ID: 17311700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The FDA approves drugs for colorectal cancer, lung cancer.
    FDA Consum; 2007; 41(1):5. PubMed ID: 17354284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.